Scandinavian Pharmaceuticals ApS: Financial statements 2021
CVR: 41233788
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
Scandinavian Pharmaceuticals ApS (CVR 41233788) has filed annual accounts for 2021. In 2021, the company reported a net result of DKK -2,402 compared with DKK -2,402 the year before. Equity in the 2021 report amounted to DKK 40,000. The solvency ratio was 100%.
- Profit/Loss
- DKK -2,402
- Equity
- DKK 40,000
- Total Assets
- DKK 40,000
Official annual report
Find more companies like Scandinavian Pharmaceuticals ApS
Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.
Try the lead list generatorEvents in 2021
Scandinavian Pharmaceuticals ApS has published its interim report for the period February 29, 2020 to December 31, 2020.
About Scandinavian Pharmaceuticals ApS
Scandinavian Pharmaceuticals ApS is a Danish company of the type Anpartsselskab based in Viby J, founded in 2020. The company is registered under the industry Vikarbureauers aktiviteter og anden personaleformidling. The management consists of Ali Jasim Mohammad Jamil. The company is owned by Ali Jasim Mohammad Jamil. In 2025, the company reported a gross profit of DKK 0 and a net result of DKK 0 compared with DKK 0 the year before. Equity in the 2025 report amounted to DKK 40,000.